Abstract:BackgroundIn the United States, about 3 million people have autism spectrum disorder (ASD), and around 1 out of 59 children are diagnosed with ASD. People with ASD have characteristic social communication deficits and repetitive behaviors. The causes of this disorder remain unknown; however, in up to 25% of cases, a genetic cause can be identified. Detecting ASD as early as possible is desirable because early detection of ASD enables timely interventions in children with ASD. Identification of ASD based on objective pathogenic mutation screening is the major first step toward early intervention and effective treatment of affected children. ObjectiveRecent investigation interrogated genomics data for detecting and treating autism disorders, in addition to the conventional clinical interview as a diagnostic test. Since deep neural networks perform better than shallow machine learning models on complex and high-dimensional data, in this study, we sought to apply deep learning to genetic data obtained across thousands of simplex families at risk for ASD to identify contributory mutations and to create an advanced diagnostic classifier for autism screening. MethodsAfter preprocessing the genomics data from the Simons Simplex Collection, we extracted top ranking common variants that may be protective or pathogenic for autism based on a chi-square test. A convolutional neural network–based diagnostic classifier was then designed using the identified significant common variants to predict autism. The performance was then compared with shallow machine learning–based classifiers and randomly selected common variants. ResultsThe selected contributory common variants were significantly enriched in chromosome X while chromosome Y was also discriminatory in determining the identification of autistic individuals from nonautistic individuals. The ARSD, MAGEB16, and MXRA5 genes had the largest effect in the contributory variants. Thus, screening algorithms were adapted to include these common variants. The deep learning model yielded an area under the receiver operating characteristic curve of 0.955 and an accuracy of 88% for identifying autistic individuals from nonautistic individuals. Our classifier demonstrated a considerable improvement of ~13% in terms of classification accuracy compared to standard autism screening tools. ConclusionsCommon variants are informative for autism identification. Our findings also suggest that the deep learning process is a reliable method for distinguishing the diseased group from the control group based on the common variants of autism.

Cell type-specific predictive models for prioritizing genes and gene sets associated with autism spectrum disorder

Cell Type-Specific Predictive Models Perform Prioritization of Genes and Gene Sets Associated With Autism

Gene Screening for Autism Based on Cell-type-specific Predictive Models.

Diagnostic Classification and Prognostic Prediction Using Common Genetic Variants in Autism Spectrum Disorder: Genotype-Based Deep Learning

Cell Type-Specific Gene Network-Based Analysis Depicts the Heterogeneity of Autism Spectrum Disorder

Human Brain Cell Type-Specific Gene Co-Expression Associated with Autism Spectrum Disorder

Shared and Cell-Type-Specific Gene Expression Patterns Associated with Autism Revealed by Integrative Regularized Non-Negative Matrix Factorization

Gene Module Analysis Reveals Cell-Type Specificity and Potential Target Genes in Autism’s Pathogenesis

Cell type-specific expression analysis to identify putative cellular mechanisms for neurogenetic disorders.

An analytical method for the identification of cell type-specific disease gene modules

Modelling cell type-specific lncRNA regulatory network in autism with Cycle

Cell Type Specific Analysis of Human Brain Transcriptome Data to Predict Alterations in Cellular Composition.

Prediction and prioritization of autism-associated long non-coding RNAs using gene expression and sequence features

Molecular cascades and cell type–specific signatures in ASD revealed by single-cell genomics

Single-cell genomics identifies cell type–specific molecular changes in autism

Predictive Models for Subtypes of Autism Spectrum Disorder Based on Single-Nucleotide Polymorphisms and Magnetic Resonance Imaging.

Prioritizing Autism Risk Genes Using Personalized Graphical Models Estimated From Single-Cell RNA-seq Data

Exploiting Aberrant Mrna Expression in Autism for Gene Discovery and Diagnosis

High-throughput single-cell functional elucidation of neurodevelopmental disease-associated genes reveals convergent mechanisms altering neuronal differentiation

Unraveling the immunogenetic landscape of autism spectrum disorder: a comprehensive bioinformatics approach

Artificial intelligence and bioinformatics analyze markers of children's transcriptional genome to predict autism spectrum disorder